Algert Global LLC Vera Therapeutics, Inc. Transaction History
Algert Global LLC
- $4.25 Billion
- Q4 2024
A detailed history of Algert Global LLC transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Algert Global LLC holds 38,550 shares of VERA stock, worth $1.03 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
38,550
Previous 23,164
66.42%
Holding current value
$1.03 Million
Previous $1.02 Million
59.18%
% of portfolio
0.04%
Previous 0.03%
Shares
4 transactions
Others Institutions Holding VERA
# of Institutions
192Shares Held
63.9MCall Options Held
68.1KPut Options Held
88.6K-
Avoro Capital Advisors LLC New York, NY5.61MShares$149 Million3.46% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.38MShares$117 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$88.9 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$78.8 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.95MShares$78.5 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $720M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...